Introduction
Escherichia coli strains that possess the K1 capsular antigen are the most frequent cause of meningitis in the newborn (Speer et al., 1985) and of nosocomial gram-negative bacteraemia with gram-negative bacilli in adults (Weinstein et al., 1983) . The K polysaccharide is recognised to be a virulence factor responsible for bacterial resistance to phagocytosis and the bactericidal action of serum (Horwitz and Silverstein, 1980) . Antibodies to the capsular polysaccharide are protective in experimental E. coli infections (Bortolussi and Ferrieri, 1980; Cross et al., 1983) , but unfortunately the K 1 antigen is a poor immunogen. The 0-antigenic polysaccharide part of the E. coli lipopolysaccharide (LPS) is, similarly, a target of protective antibodies (Kaijser et al., 1972) . Recently Pluschke and Achtman (1985) reported that monoclonal IgM antibodies to the 0 1 8 serotype protected infant rats from meningitis caused by capsulate E. coli 018:Kl. Antibodies to deeper structures of LPS (core glycolipid-lipid A) have been reported to be effective in preventing fatal infections with gram-negative bacilli (Ziegler et published (Greisman et al., 1978; Welch et al., 1979) .
The major outer-membrane (OM) proteins, including porins and the OmpA protein, show antigenic cross-reactivity within the family Enterobacteriaceae (Hofstra and Dankert, 1980) , and this has raised the possibility of their use as vaccines (Kuusi et al., 1979) . However, van der Ley et al. (1986) have recently shown that anti-porin antibodies could not bind to their target antigen on smooth E. coli. Furthermore, SaxCn et al. (1986) showed that the protective action of polyclonal anti-porin sera in mouse salmonellosis was due to anti-0 rather than anti-protein antibodies.
We have systematically examined the role of antibodies to the major cell-surface antigens (capsule, 0 antigen, LPS core, and major outermembrane proteins) in protection from experimental mouse peritonitis-septicaemia caused by capsulate E. coli 0 1 8 : K 1.
Materials and methods

Bacteria
For mouse challenge we used E. coli strain IH 3080 (serotype 0 1 8ac : K 1 : H7) which was a clinical isolate from human neonatal meningitis (Nowicki et af., 1986) . It was stored at -70°C in small volumes until use. The inoculum for injection into the mice was prepared by growing the bacteria overnight in Luria Broth (Tryptone, Difco, 5 g/L; Yeast Extract, Difco, 5 g/L; NaCl 5 g/L (PH 7.0) at 37°C on a rotatory shaker then diluting the culture 1 in 10 and growing for a further 2 h in similar conditions.
Strain EH 778 was a spontaneous non-capsulate mutant of strain IH 3080 selected on the basis of resistance to the K1 capsule-specific phage, pKla (Gross et al., 1977) . Strain EH 786 was a rough, non-capsulate mutant of strain EH 778 selected on the basis of resistance to the LPS-specific phage, C21 (Wilkinson et al., 1972) . Strain J5 (Elbein and Heath, 1965 ) was a rough, UDP-galactose epimerase-deficient mutant of E. coli 0 1 11 received from Dr E. Ziegler, San Diego, CA, USA. Strain EH 219 was strain W 3350, a K-12 rough strain of E. coli (Makela and Stocker, 1984) and lacking the OmpA protein (SaxCn et al., 1986) . Strain SH 9013 was his-515 (Nikaido et al., 1967) , a his-rfb deletion mutant of S. typhimurium; its LPS was of chemotype Ra. Strain SH 6929 was a leaky rough (rfa) derivate of S. typhimurium LT2 (M. Nurminen at this Institute, personal communication).
Triton X treated envelopes. Triton X 100 (TX)-treated lysozyme-ethyleneaminetetra-acetate (EDTA) envelopes were prepared according to Nurminen (1978) .
Crudeporin. This was prepared by a modification of the method of Kuusi et al. (1979) . Briefly, 15 mg wet weight of TX-envelopes were treated with 0.2 M MgC12 in 100ml of sodium dodecyl sulphate (SDS) 4% for 30 min at 50°C. After centrifugation at 13 000 g for 10 min the sediment was treated with 40 ml of Tx-100 0.2% in the presence of 0.05 M EDTA and 0-3 M NaCl for 60min at 45°C. Tris-buffer (PH 8.6) was added to the mixture until the pH was over 8. Thereafter 2.5 mg of trypsin was added and the mixture was incubated overnight at 37°C. The mixture was then concentrated in an Amicon Diaflo apparatus with an XM-50 filter.
PuriJied porins. These were prepared as previously described (SaxCn et al., 1986) . TX-envelopes were electrodialysed by keeping the temperature below 30"C, and centrifuged for 10 min at 10 000 g. The pH of the sediment was raised to 8 in the presence of TX-100 2% to dissolve the porins. After centrifugation the supernate was treated overnight with trypsin at 37°C and the porins were precipitated overnight with 0.3 M NaCl, pH 6 at 42°C. After centrifugation they were dissolved in SDS 4% and further purified by gel filtration in an Ultrogel AcA 34 1.6 x 100 cm column (LKB, Bromma, Sweden) previously equilibrated with 10 mM phosphate buffer,pH 7-1 containing SDS 0-25%, mercaptoethanol 0.05% and 5 mM EDTA. The porin-containing fractions, as determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) were collected and used as purified porins. In all preparations the porins were present as high-mo1.-wt complexes, as judged by SDS-PAGE of the unheated preparations, which probably represented porin trimers, the major native form of porins (SaxCn et al., 1986) . The purified preparations were relatively free of contaminating proteins as judged by SDS-PAGE and the LPS contamination of the preparations was estimated to be <0.5% w/w of its protein content by comparison of silver-stained SDS-PAGES (Tsai and Frasch, 1982) of the porin preparations and LPS standards (SaxCn et al., 1986) . For immunisation and enzyme immunoassay (EIA) the SDS of the purified porins was exchanged for TX-100 0.02% by extensive dialysis.
Reconstituted porin. This was prepared as described before (SaxCn et al., 1986) by mixing 1 mg of purified porin with 0.1 mg of R-form EPS, that had been obtained from S. typhimurium mutant SH 6929, in the SDScontaining phosphate buffer, as above. The excess of the buffer was removed by ultrafiltration (Amicon PM-30 filter) or, in some cases, by dialysis against sterile water. Triton X-100 0.02% was added to the reconstituted preparations to keep the porins in solution.
OmpA. Two separate methods were used to prepare OmpA. Firstly, the TX envelopes (5 mg of protein) were treated with trypsin for 2 h at 37°C and electrophoresed in 15% preparative SDS-acrylamide gel (Kallio et al., 1986) . The OmpA of mol-wt 24 x lo3 was eluted from the gel with SDS 0.05% at 37°C overnight. SDS was removed by dialysis and the protein was concentrated by vacuum dialysis. By the second method, the TX envelopes were first electrodialysed. After centrifugation the pH of the sediment was raised to 8.6 in the presence of TX-100 2% followed by sonication and centrifugation. The supernate was precipitated with 0 . 3~ NaCl at pH 4-5. The mixture was then centrifuged and the pellet was dissolved in TX-100 0.2% and 0-1 mM Tris buffer. The insoluble precipitate was discarded and the NaCl precipitation repeated. After centrifugation, SDS(4%)-buffer was added to the sediment followed by ultrogel filtration. The OmpA-containing peak, as determined by SDS-PAGE, was collected and run in SDS( lO%)-PAGE. The OmpA-containing band was eluted from the gel with SDS(4%)-buffer followed by vacuum concentration.
Lipoprotein. Lipoprotein was extracted from the K-12 strain EH 219 as described by Braun et al. (1976) .
Lipopolysaccharide. Two methods were used to isolate LPS. R-form LPS was isolated from SH 6929 according to the method of Galanos et al. (1969) and 018-LPS from EH 778 according to the method of Westphal and Jann (1 965).
Antisera
Hyperimmune rabbit sera were obtained after subcutaneous immunisation of White New Zealand rabbits by four injections over a period of 6 weeks of 100-500 pg of protein or 10' heat-killed bacteria/injection (SaxCn and Makela, 1982) without adjuvant, or by three injections into the popliteal lymphnodes (Leinonen, 1985) of 30pg of proteinlinjection over a period of 4 weeks.
The rabbits were bled 10 days after the last injection. The K 1 capsule-specific hyperimmune serum of a horse (H46) immunised with Neisseria meningitidis type B was a gift from Dr J. Robbins, National Institute of Health, Bethesda, MD, USA.
Separation of rabbit immunoglobulin classes: Separation of IgG and IgM fractions was performed as described previously (Reif, 1969; SaxCn et al., 1986) . One ml of antiserum was diluted with 3 ml of water at 4°C and 10 g of wet DEAE cellulose equilibrated topH 8-0 with 0.01 M phosphate buffer was added. After incubation for 60 min at 4"C, the DEAE cellulose was removed, and the supernate was called the IgG fraction. Another 1 ml of serum was added to 6 ml of 0.1 M phosphate buffer at pH 8.0; then 7 ml of wet protein A-Sepharose was added and the mixture was incubated at 4°C with occasional stirring. The sorbent was removed by filtration and the filtrate was called the IgM fraction.
Antibody assays
Antibody titres were determined by enzyme immunoassay (EIA) (Engvall and Perlmann, 1972) , essentially as described earlier (SaxCn and Makela, 1982) . Method (a): 96-well plates (Flat Bottom Microelisa plates ; Immulon, Dynatech, London) were coated with 100 p1 of antigen diluted in PBS, pH 7-4. The optimum antigen concentration for coating the microtitration wells was 5 pg/ml for the purified E. coli porins, 1 pg/ml for purified salmonella porin, 1 pg/ml for E. coli OmpA-protein and 1 pg/ml for purified lipoprotein. Purified 0 1 8-LPS (1 pg/ml) was diluted in PBS pH 7-4, containing FCS 10% (PBS-FCS). A negative control well containing FCS 10% only was included in each assay. Thereafter the plates were washed three times with PBS containing Tween 0.05%. Antiserum diluted in PBS-FCS was added to the plates (100 pl/well) for 2 h at 37°C followed by washing as above. Peroxidase-conjugated goat anti-rabbit IgG and IgM (Cappel Laboratory, Cochranville, PA 19330, USA) diluted 1 in 2000 in PBS-FCS were added to the wells for 1 h at 20°C. After washing as above, 1OOpl of the substrate (4 mg of 1,2-phenyldiaminedihydrochloride, Fluka AG, Buchs SG, Switzerland, and 4 pl of 30% H202 in 10 ml of phosphate-citrate-buffer, pH 5.5) was added to each well. The enzyme reaction was allowed to proceed for 15 min at 20°C and then stopped with 50 p1 of 4 N H,SO,. The absorbance was measured in a Titertek Multiskan spectrophotometer (Labsystems, Helsinki, Finland) at 495 nm. The titres were expressed as log 10. Method (b): as a modification of method (a), whole cell-EIA was performed by entrapping whole bacteria on filters of a 96-well filtration plate (Millititer GV96-well Filtration Plate, Millipore Corporation, Bedford, MA, USA) employing the Millititer Filtration system. The plates were first precoated with 150 pl of PBS-FCS for 1 h at 20°C. Bacteria from the early exponential phase culture (lo6 cfu in PBS) were added to each well followed by washing three times with PBS by filtration in a Vacuum Holder. The bacteria were then incubated for 1 h at 20°C with 150 pl of antiserum diluted in PBS-FCS.
After washing by filtration, 150 pl of peroxidase-conjugated antibody (as in method (a)) was added to the wells for 30 min at 20°C. The washing step was repeated. After incubation for 15 min at 20°C with 150 pl of the substrate, the reaction was stopped as before. The coloured substrate was then transferred to a standard microtitration plate and the absorbance was measured.
Mouse protection assay
(CBA x C57B1/6) F1 hybrid mice bred at this Institute (5-10 weeks old) were used in all assays. The mice were passively immunised by an intraperitoneal or an intravenous injection of 0-2 ml of different dilutions of antisera or their fractions inactivated at 56°C for 30 min. Control animals were similarly given NaCl 0.9%. The bacterial challenge (1 0-fold dilutions of exponentially-growing bacteria of strain IH 3080 in 0.2 ml of NaCl 0.9%) was injected intraperitoneally 2 h after the serum injection. The LD50 was determined from the 5-day survival data (Reed and Muench, 1938 ) of groups of 6 mice each.
Protein assays
The protein content was determined by the method of Lowry et al. (1951) . The SDS-PAGE of proteins was performed in slabs by the method of Laemmli (1970) .
Results
The experimental infection model
The mortality-dose response curve with the capsulate E. coli, serotype 0 18 : K 1 : H7 (strain IH 3080) was steep (figure). The LD50 for the strain was estimated from several experiments to be 4 x lo5 bacteria. The course of the infection was rapid; most deaths occurred 2448 h after challenge. With inocula below the LD50, the numbers of live bacteria in the peritoneal cavity and blood began to decrease by 12 h and were completely cleared by 24 h.
Protective efects of anti-K and anti-0 sera
Antiserum to the K 1 capsular polysaccharide protected the mice from lethal infection, and the maximum increase in LD50 achieved was 10-fold (figure). When the challenge dose was c. 2.5 LD50, 0.02 pl of the antiserum per mouse (corresponding to c. 28 ng of anti-capsular antibodies; Allen et al., 1982) was sufficient to give 50% protection.
Protection was also provided with anti-0 antiserum obtained by immunising rabbits with whole heat-killed E. coli 018. A dose of 9 pl of the antiserum per mouse was needed to give 50% protection from c. 2-5 LD50 (table I). The maximum increase in LD50 obtained with a larger dose of the antiserum (20 pl/mouse) was 5-fold (figure).
Neither antiserum changed the median time to death of the mice. The protective effect of both antisera remained the same irrespective of whether the antiserum was administered intravenously or intraperitoneally (data not shown).
Ig class of the protective antibodies
The horse anti-K1 serum used and proved to be protective contained predominantly IgM-class antibodies to the K1 polysaccharide (Allen et al., protection .compared to 9 p1 of the unfractioned antiserum. The IgM fraction was not protective at the maximum dose of 67 pl used. The unfractionated serum had a high titre of anti-0 antibodies of both the IgG and IgM classes as measured by Ig class-specific EIA with the 0 1 8-LPS as antigen (table I) . The EIA titres of the fractions showed that the fractionation had been successful, because the IgG fraction showed no reactivity with antiIgM, and vice versa.
Antibodies to other outer-membrane components
Rabbits immunised with purified or semi-purified outer-membrane proteins, porins or OmpA developed high titres of IgG antibodies measurable by EIA (table 11) . By contrast, none of the sera gave measurable IgM titres. The highest antibody titre was usually obtained with the homologous antigen, but moderate titres to LPS and protein antigens were also detected, probably indicating the presence of impurities in the immunising preparations.
The anti-018 titres in all of these sera were more than 10-fold lower than the corresponding titre of the protective anti-0 18 whole bacterial serum. Titres against the 018 LPS antigen were also found in the sera of rabbits immunised with preparations derived from heterologous bacteria, the rough E. coli J5 or salmonellae. These titres probably indicate antibodies directed to antigenic determinants of the common LPS core structures (table 11) . Antisera raised to the porin preparations that were derived from the rough non-capsulate E. coli reacted most strongly with the homologous porin, whereas antisera to porins prepared from E. coli J5 or S. typhimurium elicited equally high titres to at least one of the heterologous porin preparations. The anti-OmpA sera gave very high anti-OmpA titres and also variable titres to the porin preparations and lipoprotein. By contrast, serum from the rabbit immunised with whole J5 bacteria gave relatively low titres to all the protein antigens tested, similar to those of the antiserum to whole 018 bacteria (table 11) .
When the sera were tested for their binding to whole intact bacteria (table 111) , only the anti-018 serum bound to the parental 018:Kl bacteria. Its non-capsulate (01 8 : K 1 -) mutant bound antibodies from the anti-018 serum and also to a lesser extent from the anti-J5 serum. By contrast, only the rough non-capsulate organisms (0 1 8 -: K 1 -or J5) bound > 676
anti-J5 bacteria
J5
< 3 3-6 3.2 3.7 3-9 3.1
Reconstituted with Salmonella R form-LPS as described in Methods.
' Prepared by Method 2 (see OmpA, in Methods).
Prepared by Method 1 (see OmpA, in Methods). The figures are log 10 of the reciprocal of the dilution giving the absorbance of 0.2 at 495 nm. The IgM titres (not shown) were < 2 for each serum and antigen except for anti-018 LPS antiserum shown in table I.
' (i) Serum was given intraperitoneally in a total volume of 0-2ml. (ii) the bacterial challenge (2-5xLD50) was given intraperitoneally in a volume of 0.2 m12 hrs after the intraperitoneal serum injection; 5 days observation.
(r2 mice out of 6 tested survived the largest serum dose tested. <2-7 <2*7 n.t., not tested.
* log 10; the IgM titres (not shown) were <2 for each serum.
efficiently to antibodies from the anti-protein or anti-J5 sera. Despite the high titres of antibodies to various E. coli surface components, none of the rabbit antisera to the OM proteins or to the J5 bacteria were protective even at doses as high as 67 pl of antiserum/mouse when the E. coli challenge was 2.5 LD50. Only 0-2 mice out of 6 treated with either the immune sera or NRS survived the challenge; in the saline-treated group none survived (table 11) . When the challenge dose was 0.75LD50 the survival rates in the groups treated with NaCl and NRS were 5 of 6 (83.3%) and 2 of 6 (30%), respectively. The numbers of surviving mice in the groups receiving the different immune sera were 1-5 out of 6 mice.
Discussion
Our E. coli peritonitis-septicaemia model bears similarities to infections with gram-negative bacilli in man, making it suitable to study the role of antibodies in host defence against E. coli. Its advantages are that it does not require adjuvants or a specially sensitised host, that the LD50 is low and the challenge E. coli causes natural infection in man. We found that antibodies to the capsular polysaccharide and to the 0 antigen were protective whereas those directed against several other outermembrane structures were not.
The role of anti-capsular antibodies in protection against capsulate bacteria, including E. coli K1, is well documented (Robbins 1978) . Recently even monoclonal anti-K 1 antibodies have been shown to protect against experimental E. coli K 1 infection (Kim et al., 1985) . Our results with the hyperimmune antiserum to N. meningitidis group B capsular polysaccharide, which is immunochemically identical to the K1 E. coli capsule (Kasper et al., 1973) , are in agreement with these findings.
The role of anti-LPS antibodies in protection against capsulate organisms is less clear. In some studies, antibodies to the outermost part of LPS, the 0 antigen, have been protective (Kaijser et al., 1972; Pluschke and Achtman, 1985) , but in others they have not been (Welch et al., 1979) . In this study we observed definite protection with a hyperimmune rabbit anti-01 8 antiserum against challenge with capsulate 0 1 8 : K 1 bacteria. The 018 antiserum also contained antibodies to several outer-membrane proteins, but the highest titre was found with the homologous 018-LPS. An immunoblotting analysis revealed that the anti-018 antiserum reacted with the polysaccharide chain and with deeper LPS structures of the core region (data not shown) which explains why these antibodies were able to bind to rough as well as to smooth capsulate E. coli bacteria in EIA (table 111) . Although the protective effect of anti-0 serum was weaker than that of the anti-K1 serum, the protection obtained shows that 0-antigenic LPS was exposed enough on the surface of the capsulate bacteria to react with antibodies. In the study in which anti-0 antibodies were not protective, different E. coli serotypes were used (Welch et al., 1979) . The exposure of 0-antigenic LPS may vary with the strain and the 0 serotype as well as with the capsular type of the bacteria. It also seems relevant to consider the fact that anti-0 antibodies do not agglutinate capsulate E. coli unless the capsule is destroyed by heating (Kauffmann, 1966) ; however, agglutinability may require more numerous or more closely spaced antigenic sites to be exposed on the bacterial surface than is needed in vivo for the protection that is probably mediated by phagocytosis following opsonisation. The protective effect of the homologous anti-018 antiserum (or anti-K1) is unlikely to be due to in-situ agglutination of the challenge 0 18 : K 1 bacteria in the peritoneal cavity, as the route of antiserum administration had no effect on the protective capacity.
Several previous studies have reported protection afforded by anti-porin antibodies in infections with gram-negative bacilli (Kuusi et al., 1979 and 1981 ; Gilleland et al., 1984) . In these studies the possible role of contaminating anti-0 antibodies has not been ruled out, and in a recent study the protective effect of anti-porin antisera in experimental salmonellosis was, nevertheless, found to be due to the small amounts of anti-0 antibodies produced (SaxCn et al., 1986) . Therefore, we set out to examine the protective potential of different OM structures in the E. coli infection model. Rabbits were immunised with crude and purified preparations of OM components from rough 0-antigen deficient E. coli and S. typhimurium. All the preparations were immunogenic in rabbits as determined by EIA. High antibody titres to the homologous antigens, but also rather high titres to heterologous antigens (porin, OmpA protein or lipoprotein) were observed, in keeping with the reported cross-reactions between enterobacterial OM proteins (Hofstra and Dankert, 1980) . All the detected responses were of IgG class as expected for protein antigens. The low titres of anti-LPS antibodies produced were most probably directed to the core part of LPS. In contrast to the protective action of IgG anti-0 antibodies, none of the antiprotein sera afforded any protection from challenge with the capsulate E. coli. We believe that this difference is due to the different accessibility of the target antigens to their respective antibodies. Thus, the capsule and smooth type LPS are exposed on the surface of the bacteria and can prevent binding of other antibodies to deeper cell-surface components. Indeed, when van der Ley et al. (1986) studied the binding of monoclonal anti-porin (PhoE) antibodies to E. coli they found that these bound efficiently to the rough K-12 strain but not to smooth clinical isolates of E. coli. Similarly, when using the intact capsulate 018:Kl or noncapsulate 018 bacteria as EIA antigens we could not detect binding of the anti-protein antibodies although these bound effectively to rough noncapsulate E. coli. This shows that the anti-protein sera used did contain antibodies directed against native protein structures exposed on the bacterial surface. However, the 0 antigen, and probably also the capsule, prevent these antibodies from reaching their target on the surface of the OM of the smooth capsulate bacteria that cause infections.
The role of LPS core-glycolipid and lipid A in protection against infection with Enterobacteriaceae is also a subject of controversy. Whereas protection against enterobacterial infections in normal and immunosuppressed hosts has been achieved with anti-"core-glycolipid" antisera raised against E. coli J5 or rough S. minnesota, or even with a monoclonal antibody to the J5 LPS (Ziegler et al., 1973 and Braude et al., 1977; Teng et al., 1985) , others have not been able to show protection with similar preparations (Greisman et al., 1978; Welch et al., 1979; Siber et al., 1985) . We could not show any protection with anti-J5 serum against challenge with the capsulate 0 1 8 : K1 E. coli, nor could we detect binding of anti-J5 antibodies to the intact 018 : K1 bacteria. Although immunisation with a core glycolipid vaccine leads to elevated antibody titres to the homologous J5 bacteria or their LPS, these antibodies show little or no cross-reaction with the core region of other strains of Enterobacteriaceae (de Jongh-Leuvenink et al., Siber et al., 1985) . To explain these conflicting results it has been suggested that the protective effects seen with the anti-core glycolipid antisera are the result of neutralisation of endotoxin rather than of opsonisation (Ziegler et al., 1982) . Our mouse infection model is very susceptible to the size of the challenge inoculum ; thus, the protective antibodies probably also act by preventing bacterial growth. Therefore, this model would probably not be very sensitive to anti-endotoxin effects alone.
Our finding that antibodies to deeper outer-
